rs1799767

Variant names:

• chr4-54229321-CAG-C
• rs1799767
• NM_006206.6:c.-104_-103delAG

Your query was ambiguous. Multiple possible variants found:

• chr4-54229321-CAG-C
• chr4-54229321-CAG-CAGAG

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_Strong BA1

The NM_006206.6(PDGFRA):​c.-104_-103delAG variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.223 in 398,236 control chromosomes in the GnomAD database, including 10,616 homozygotes. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.25 (5016 hom., cov: 23)
  • Exomes 𝑓: 0.21 (5600 hom.)
• Consequence: PDGFRA NM_006206.6 5_prime_UTR
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:3
• Conservation: PhyloP100: 1.80

Genes affected

PDGFRA (HGNC:8803): (platelet derived growth factor receptor alpha) This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]

ENSG00000282278 (HGNC:):

ACMG classification

Our verdict: Benign. The variant received -16 ACMG points.

• BP6: Variant 4-54229321-CAG-C is Benign according to our data. Variant chr4-54229321-CAG-C is described in ClinVar as [Benign]. Clinvar id is 348893.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BA1: GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.322 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
PDGFRA	NM_006206.6	c.-104_-103delAG		5_prime_UTR_variant	Exon 1 of 23	ENST00000257290.10	NP_006197.1
PDGFRA	NM_001347828.2	c.-107_-106delAG		5_prime_UTR_variant	Exon 1 of 24		NP_001334757.1
PDGFRA	NM_001347827.2	c.-104_-103delAG		5_prime_UTR_variant	Exon 1 of 17		NP_001334756.1
PDGFRA	XM_006714041.4	c.-107_-106delAG		5_prime_UTR_variant	Exon 1 of 18		XP_006714104.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
PDGFRA	ENST00000257290.10	c.-104_-103delAG		5_prime_UTR_variant	Exon 1 of 23	1	NM_006206.6	ENSP00000257290.5
ENSG00000282278	ENST00000507166.5	c.1018-45601_1018-45600delAG		intron_variant	Intron 12 of 23	2		ENSP00000423325.1

Frequencies

GnomAD3 genomes AF: 0.248 AC: 37709 AN: 151816 Hom.: 5010 Cov.: 23

Gnomad AFR AF: 0.317

Gnomad AMI AF: 0.146

Gnomad AMR AF: 0.330

Gnomad ASJ AF: 0.101

Gnomad EAS AF: 0.197

Gnomad SAS AF: 0.251

Gnomad FIN AF: 0.207

Gnomad MID AF: 0.142

Gnomad NFE AF: 0.209

Gnomad OTH AF: 0.218

GnomAD4 exome AF: 0.207 AC: 50975 AN: 246302 Hom.: 5600 AF XY: 0.205 AC XY: 25563 AN XY: 124808

African (AFR) AF: 0.315 AC: 2265 AN: 7182

American (AMR) AF: 0.362 AC: 2688 AN: 7434

Ashkenazi Jewish (ASJ) AF: 0.106 AC: 981 AN: 9240

East Asian (EAS) AF: 0.171 AC: 3913 AN: 22892

South Asian (SAS) AF: 0.257 AC: 780 AN: 3032

European-Finnish (FIN) AF: 0.202 AC: 4207 AN: 20830

Middle Eastern (MID) AF: 0.167 AC: 216 AN: 1294

European-Non Finnish (NFE) AF: 0.205 AC: 32369 AN: 158024

Other (OTH) AF: 0.217 AC: 3556 AN: 16374

GnomAD4 genome AF: 0.249 AC: 37760 AN: 151934 Hom.: 5016 Cov.: 23 AF XY: 0.248 AC XY: 18450 AN XY: 74268

African (AFR) AF: 0.317 AC: 13112 AN: 41358

American (AMR) AF: 0.330 AC: 5038 AN: 15268

Ashkenazi Jewish (ASJ) AF: 0.101 AC: 349 AN: 3466

East Asian (EAS) AF: 0.198 AC: 1022 AN: 5170

South Asian (SAS) AF: 0.251 AC: 1208 AN: 4820

European-Finnish (FIN) AF: 0.207 AC: 2184 AN: 10574

Middle Eastern (MID) AF: 0.153 AC: 45 AN: 294

European-Non Finnish (NFE) AF: 0.209 AC: 14214 AN: 67962

Other (OTH) AF: 0.216 AC: 455 AN: 2110

Alfa AF: 0.228 Hom.: 511

Bravo AF: 0.262

ClinVar

Significance: Benign

Submissions summary: Benign:3

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Idiopathic hypereosinophilic syndrome Benign:1

Jun 14, 2016

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

not provided Benign:1

Jul 06, 2018

GeneDx

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Gastrointestinal stromal tumor Benign:1

Jun 14, 2016

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
PhyloP100		1.8
Mutation Taster		=295/5	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Other links and lift over

dbSNP: rs1799767; hg19: chr4-55095488;